COMMUNIQUÉS West-GlobeNewswire

-
Autolus Announces Proposed Public Offering in the United States
08/04/2019 -
Natus Medical to Hold 2019 First Quarter Financial Results Conference Call on April 25th
08/04/2019 -
T2 Biosystems Reports Granting of Inducement Awards
08/04/2019 -
NGM Bio Announces Multiple Presentations at The International Liver Congress™ 2019
08/04/2019 -
DBV Technologies Announces Closing of Global Offering
08/04/2019 -
DBV Technologies annonce la réalisation de son offre globale
08/04/2019 -
Daré Bioscience, Inc. Announces Proposed Public Offering of Common Stock
08/04/2019 -
Homology Medicines Announces Proposed Public Offering of Common Stock
08/04/2019 -
Translate Bio Presents Preclinical Data Supporting MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency at the Society for Inherited Metabolic Disorders (SIMD) Annual Meeting
08/04/2019 -
Alder BioPharmaceuticals® Appoints Nadia Dac as Chief Commercial Officer
08/04/2019 -
Silk Road Medical Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
08/04/2019 -
PhaseBio Receives FDA Breakthrough Therapy Designation for PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor
08/04/2019 -
Zogenix Receives Refusal to File Letter from U.S. Food and Drug Administration for FINTEPLA® New Drug Application
08/04/2019 -
Zosano Pharma Announces Proposed Public Offering of Common Stock
08/04/2019 -
Kiniksa to Present KPL-404 Preclinical Data at the Keystone Symposia on Antibodies as Drugs
08/04/2019 -
aTyr Pharma to Present Poster at the American Thoracic Society 2019 International Conference
08/04/2019 -
Zealand Pharma to attend Kempen Life Sciences Conference
08/04/2019 -
MESA LABS DECLARES QUARTERLY DIVIDEND
08/04/2019 -
Study of SPR Therapeutics’ Peripheral Nerve Stimulation System Demonstrates Significant and Sustained Relief of Post-Amputation Pain
08/04/2019
Pages